News2 mins ago
Abbott Unveils Late-Breaking Data Showing the World’s First Dual-Chamber Leadless Pacemaker Study Met All Three Primary Endpoints
Abbott’s AVEIR™ DR i2i™ IDE study is the industry’s first prospective study on the safety and performance of the world’s first dual-chamber leadless pacemaker The study...
